Medical Cannabis in Georgia: Federal Policy Effects on State Industries, Cannabis Industry Journal
Reggie Snyder discusses the impact that the U.S. Drug Enforcement Administration’s potential reclassification of cannabis would affect Georgia’s medical cannabis industry in his article published by Cannabis Industry Journal.
Mr. Snyder considers three key areas of impact:
(1) How Georgia medical cannabis distributors would operate within this new regulatory framework;
(2) How this change would affect registered Georgia patients who are either currently purchasing medical cannabis or are planning to do so; and
(3) Whether this reclassification would cause big pharmaceutical companies to enter Georgia’s medical cannabis market, and if so, how.
To read the full article, please visit the Cannabis Industry Journal.